Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients
Weill Medical College of Cornell University · with Massachusetts General Hospital · NCT06094257
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 400
- US sites recruiting
- 2
- Study start
- February 9, 2022
- Record last updated
- September 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
During breast surgery, sensory nerves are cut which may lead to reduced sensation and pain. Surgical reinnervation techniques have been developed with the aim of improving postoperative sensation by preserving the nerves and connecting them to the nipple and areola. The investigators aim to compare postoperative sensation and patient reported outcomes in patients undergoing reinnervation versus those not undergoing reinnervation to determine if there is a difference. The investigators will investigate this in patients undergoing gender-affirming mastectomy, implant-based breast reconstruction and autologous breast reconstruction. The investigators will use various tools that measure sensation quantitatively.
Being studied: Sensory testing
Conditions: Sensation Disorders; Sensation, Phantom; Pain, Postoperative; Pain, Chronic; Numbness; Sensory Disorder; Sensory Defect; Phantom Pain; Phantom Sensation
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age over 18
- Patient is scheduled for gender mastectomy surgery (including nipple sparing mastectomy and mastectomy with free nipple graft) or NSM with breast implant or autologous reconstruction
- Patient is capable and willing to provide informed consent
Exclusion Criteria
- Patient has a nerve condition that does not allow for assessment of sensation
- Any subject who at the discretion of the Investigator is not suitable for inclusion in the study or is unlikely to comply with follow-up schedule
- Currently prescribed medication known to impact nerve regeneration or to cause peripheral neuropathy
- Bilateral reconstruction with non-uniform treatment (i.e. 1 reconstructed breast is non-neurotized, 1 reconstructed breast is neurotized)
Recruiting US locations
Massachusetts General Hospital
Boston, MA 02114
Site contact: Lisa Gfrerer, MD. PhD · (646) 962-2330 · lgfrerer@partners.org
Weill Cornell Medicine
New York, NY 10065
Site contact: Lisa Gfrerer, MD, PhD · 646.962.4250 · lig4013@med.cornell.edu
Study contacts (from the official record)
- Lisa Gfrerer, MD, PhD · 646.962.4250 · lig4013@med.cornell.edu
Similar studies in Massachusetts
All pain studies in Massachusetts →- RecruitingHealthy volunteersOvernight stay mentioned
The Osteoarthritis Prevention Study
Wake Forest University
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 50+ · Women only
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Boston, MA + 57 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Eli Lilly and Company
- Location
- Burlington, MA + 37 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Eli Lilly and Company
- Location
- New Bedford, MA + 34 other US sites
- Eligibility basics
- Ages 18+